http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009044838-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24aca9ded2638ea793d05360dde7a4a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9fb165260d84dfd645114a92f52ee926
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dce74b493bd46c1b0698ef2b940833ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b108a2c5324a6c5189e5626e9578635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_70be18388573dacddba626e916954217
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D313-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D313-12
filingDate 2008-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9da4e1dd16bfe27759c242b46c72c8af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9293757eea4e3c44a577f51a9c8a098
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0b03aa7a4a2e81acdf5e5faff64c645
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0a7d24db016f9a06ffddc223c80becc
publicationDate 2009-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2009044838-A1
titleOfInvention Method for producing dibenzoxepin compound
abstract Disclosed is a method wherein (Z)-11-(3- dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin-2- acetic acid (general name: olopatadine) or an acid addition salt thereof, which is useful as a pharmaceutical product, is produced by processing a dibenzoxepin derivative represented by the formula [I] below with a dehydrating agent for obtaining a mixture of a dibenzoxepin derivative represented by the formula [II] below and a dibenzoxepin derivative represented by the formula [III] below, and then processing the thus-obtained mixture with an acid. (In the formula [I], R1, R2 and R3 independently represent an alkyl group having 1-2 carbon atoms.) (In the formula [II], R1, R2 and R3 are as defined above.) (In the formula [III], R1, R2 and R3 are as defined above.)
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011033532-A1
priorityDate 2007-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006010459-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6310784-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H11279158-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128250517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60865
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13011298
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284599
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396616
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129899378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226677538
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281071
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396615

Total number of triples: 31.